Plunkett Research Online: Oncternal Therapeutics Inc

ONCTERNAL THERAPEUTICS INC (ONCT) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need. The Company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to ROR1 (Receptor-tyro.....


ONCTERNAL THERAPEUTICS INC

Ticker: ONCT
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 858 434-1113
Fax: 858 408-3010
Address: 12230 El Camino Real Suite 300
San Diego, CA 92130 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

David HaleChairman of the Board/Director
Rajesh KrishnanChief Scientific Officer/Chief Technology Officer
See More
Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need. The Company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to ROR1 (Receptor-tyro.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture